EFPIA - NEWSLETTER

EFPIA Newsletter 23 June 2022

News

23 June 2022 EFPIA welcomes the launch of the EU NCDs Initiative (1)

The EU NCDs Initiative shows renewed political attention to NCDs and delivers a broad, integrated policy response across...

22 June 2022 EFPIA statement on the establishment of the HTA Coordination Group

Europe has a unique opportunity to enact real step change in how it can attract and bring innovation to patients

17 June 2022 EFPIA is deeply disappointed about the decision taken by World Trade Organization (WTO) at...

The decision is a serious retrograde step in our collective ability to tackle the COVID-19 pandemic and future global...

Blogs

23 June 2022 The EFPIA Disclosure: Where are we for the 7th publication?

In the context of increasing societal expectations on transparency, the disclosure requirements seek to address any...

23 June 2022 Cancer care for women: Why we must continue to strive for equal access

For cancer patients to live fuller, healthier and more informed lifestyles, it is vital that we work together to bridge...

23 June 2022 Elevating the experience of men with cancer

To mark #MensHealthMonth, Jacqueline Daly, member of the Let’s Talk Prostate Cancer (LTPC) Expert Group and co-founder...

23 June 2022 Supply Chains reshaping - How to respond to a crisis

#RegulatoryRoadtoInnovation

22 June 2022 5 ways to tackle Europe’s diabetes crisis

Better data, action on inequality, and health system reforms are vital

20 June 2022 Maximising the EHDS impact on better health data sharing

Sharing data from one or several individuals can help treat, cure, or save another

EFPIA Conference | 29 June 2022

What we are reading

We must seize this opportunity, says EFPIA Director General Nathalie Moll 20 June 2022 (Hospimed)

EU Project Findings To ‘Instil Confidence’ In Using Patient Preference Studies 16 June 2022 (Pink Sheet)

We’re already ignoring the next pandemic 07 June 2022 (Harvard Public Health)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶